These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7357745)

  • 41. [Improved diagnostic evaluation of prostatic neoplasms using radioimmunoassay for prostatic acid phosphatase].
    Gaca A; Panitz N
    Helv Chir Acta; 1981 Aug; 48(3-4):465-6. PubMed ID: 7287485
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Role of gamma-seminoprotein (gamma-SM) and prostatic acid phosphatase (PAP) as tumor markers of prostatic cancer].
    Watanabe M; Kitamura Y; Komatsubara S; Sakata Y
    Hinyokika Kiyo; 1988 Dec; 34(12):2135-41. PubMed ID: 2467542
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of radioimmunological and conventional acid phosphatase assays in the serum of prostatic cancer patients.
    Vihko P; Jokipalo A; Tenhunen R; Alfthan O; Oravisto KJ
    Scand J Urol Nephrol; 1982; 16(2):105-8. PubMed ID: 7123159
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Simple assay for serum prostatic acid phosphatase with specific monoclonal antibody.
    Lin MF; Lee CL; Chu TM
    Clin Chim Acta; 1983 May; 130(2):263-7. PubMed ID: 6872260
    [No Abstract]   [Full Text] [Related]  

  • 45. Discriminative value of serum phosphatases in patients with prostatic carcinoma.
    Lämmel A; Krieg M; Becker H; Braun BE
    Urology; 1988 Oct; 32(4):293-300. PubMed ID: 2845624
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical utility of serum prostatic acid phosphatase measurements for detection (screening), diagnosis, and therapeutic monitoring of prostatic carcinoma; assessment of monoclonal and polyclonal enzymes and radioimmunoassays.
    Kaplan LA; Chen IW; Sperling M; Bracken B; Stein EA
    Am J Clin Pathol; 1985 Sep; 84(3):334-9. PubMed ID: 4036863
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The contemporary value of pretreatment prostatic acid phosphatase to predict pathological stage and recurrence in radical prostatectomy cases.
    Moul JW; Connelly RR; Perahia B; McLeod DG
    J Urol; 1998 Mar; 159(3):935-40. PubMed ID: 9474187
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Tumor markers of prostate cancer--evaluation of serum PAP and PA].
    Miki M
    Gan No Rinsho; 1985 May; 31(6 Suppl):664-9. PubMed ID: 2411965
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Counterimmunoelectrophoresis in determination of prostatic acid phosphatase in human serum.
    Foti AG; Cooper JF; Herschman H
    Clin Chem; 1978 Jan; 24(1):140-2. PubMed ID: 618643
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Quantitative counterimmunoelectrophoresis assay for prostatic acid phosphatase.
    Killian CS; Vargas FP; Lee CL; Wang MC; Murphy GP; Chu TM
    Invest Urol; 1980 Nov; 18(3):219-24. PubMed ID: 7429782
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prostatic acid phosphatase: current concepts.
    Romas NA
    Semin Urol; 1983 Aug; 1(3):177-85. PubMed ID: 6379804
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Carcinoma of the prostate. II. Serum activity of acid phosphatase, prostatic acid phosphatase, LDH and its isoenzymes.
    Mráz J; Vrubel F; Hanselová M
    Int Urol Nephrol; 1979; 11(4):301-9. PubMed ID: 536179
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prostatic specific antigen and prostatic acid phosphatase in the monitoring and staging of patients with prostatic cancer.
    Ercole CJ; Lange PH; Mathisen M; Chiou RK; Reddy PK; Vessella RL
    J Urol; 1987 Nov; 138(5):1181-4. PubMed ID: 2444720
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Radioimmunoassayable prostate-specific acid phosphatase in peripheral and bone marrow sera compared in diagnosis of prostatic cancer patients.
    Vihko P; Kontturi M; Lukkarinen O; Vihko R
    J Urol; 1982 Oct; 128(4):739-41. PubMed ID: 6183458
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Screening for carcinoma of the prostate. Rectal examination, and enzymatic and radioimmunologic measurements of serum acid phosphatase compared.
    Vihko P; Kontturi M; Lukkarinen O; Ervasti J; Vihko R
    Cancer; 1985 Jul; 56(1):173-7. PubMed ID: 4005787
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Studies on the measurement of serum prostatic acid phosphatase with RIA-Quant PAP test kit (author's transl)].
    Kawamura J; Yoshida O; Kousaka T; Yoshii M; Morita R; Torizuka K
    Kaku Igaku; 1982 Mar; 19(2):313-22. PubMed ID: 7109329
    [No Abstract]   [Full Text] [Related]  

  • 57. Preliminary evaluation of measurement of serum prostate-specific antigen level in detection of prostate cancer.
    Wang TY; Kawaguchi TP
    Ann Clin Lab Sci; 1986; 16(6):461-6. PubMed ID: 3800301
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sodium thymolphthalein monophosphate: a new acid phosphatase substrate with greater specificity for the prostatic enzyme in serum.
    Roy AV; Brower ME; Hayden JE
    Clin Chem; 1971 Nov; 17(11):1093-102. PubMed ID: 5127366
    [No Abstract]   [Full Text] [Related]  

  • 59. The stability of prostatic acid phosphatase, as measured by a capture immunoenzyme assay.
    Lin TM; Chin-See MW; Halbert SP
    Clin Chim Acta; 1984 Mar; 138(1):73-86. PubMed ID: 6370510
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunochemical detection of serum prostatic acid phosphatase. Methodology and clinical evaluation.
    Chu TM; Wang MC; Scott WW; Gibbons RP; Johnson DE; Schmidt JD; Loening SA; Prout GR; Murphy GP
    Invest Urol; 1978 Jan; 15(4):319-23. PubMed ID: 75196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.